Abstract
Indan derivatives, namely, 5-(5',6'-dichloroindan-1'-yl)-tetrazole (12a) and 5-(5',6'-dichloroindan-1'-yl)- methyltetrazole (12b), were synthesized conveniently from 5,6-dichloroindan-1-carboxylic acid (9a) and 5,6- dichloroindan-1-acetic acid (9b), respectively, as potential analgesic and anti-inflammatory agents. The analgesic and anti-inflammatory properties of 9a, 9b, 12a and 12b were evaluated by the acetic acid induced writhing in Swiss albino mice and the carrageenan-induced rat paw edema models, respectively. Compounds 9a and 12a exhibited significant analgesic activity with the doses of 50 and 100 mg/kg body weight, comparable to that of the positive controls, phenylbutazone, indomethacin and aminopyrine. The anti-inflammatory potencies of 9a and 12a were also comparable to that of the positive control, phenylbutazone. Compounds 9b and 12b showed analgesic and anti-inflammatory activities, but were weaker than that of compounds 9a and 12a.
Keywords: Indan acids, Indanyl tetrazoles, 5, 6-dichloroindan-1-carboxylic acid, 5, 6-dichloroindan-1-acetic Acid, 5-(5', 6'- dichloroindan-1'-yl)-tetrazole, 5-(5', 6'-dichloroindan-1'-yl)-methyltetrazole, Carrageenan, Analgesic activity, Antiinflammatory activity
Medicinal Chemistry
Title:Synthesis of 5,6-Dichloroindan-1-Acids and their Tetrazolyl Derivatives as Analgesic and Anti-inflammatory Agents
Volume: 8 Issue: 5
Author(s): Rajib Kumar Pal, Hasina Yasmin, Lutfun Nahar, Bidyut Kanti Datta, Abul Kalam Azad Chowdhury, Joydeb Kumar Kundu, Sitesh Chandra Bachar and Satyajit Dey Sarker
Affiliation:
Keywords: Indan acids, Indanyl tetrazoles, 5, 6-dichloroindan-1-carboxylic acid, 5, 6-dichloroindan-1-acetic Acid, 5-(5', 6'- dichloroindan-1'-yl)-tetrazole, 5-(5', 6'-dichloroindan-1'-yl)-methyltetrazole, Carrageenan, Analgesic activity, Antiinflammatory activity
Abstract: Indan derivatives, namely, 5-(5',6'-dichloroindan-1'-yl)-tetrazole (12a) and 5-(5',6'-dichloroindan-1'-yl)- methyltetrazole (12b), were synthesized conveniently from 5,6-dichloroindan-1-carboxylic acid (9a) and 5,6- dichloroindan-1-acetic acid (9b), respectively, as potential analgesic and anti-inflammatory agents. The analgesic and anti-inflammatory properties of 9a, 9b, 12a and 12b were evaluated by the acetic acid induced writhing in Swiss albino mice and the carrageenan-induced rat paw edema models, respectively. Compounds 9a and 12a exhibited significant analgesic activity with the doses of 50 and 100 mg/kg body weight, comparable to that of the positive controls, phenylbutazone, indomethacin and aminopyrine. The anti-inflammatory potencies of 9a and 12a were also comparable to that of the positive control, phenylbutazone. Compounds 9b and 12b showed analgesic and anti-inflammatory activities, but were weaker than that of compounds 9a and 12a.
Export Options
About this article
Cite this article as:
Kumar Pal Rajib, Yasmin Hasina, Nahar Lutfun, Kanti Datta Bidyut, Kalam Azad Chowdhury Abul, Kumar Kundu Joydeb, Chandra Bachar Sitesh and Dey Sarker Satyajit, Synthesis of 5,6-Dichloroindan-1-Acids and their Tetrazolyl Derivatives as Analgesic and Anti-inflammatory Agents, Medicinal Chemistry 2012; 8 (5) . https://dx.doi.org/10.2174/157340612802084234
DOI https://dx.doi.org/10.2174/157340612802084234 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach
CNS & Neurological Disorders - Drug Targets Chondroitin Sulphate: Antioxidant Properties and Beneficial Effects
Mini-Reviews in Medicinal Chemistry Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials
Current Pharmaceutical Design An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes
Current Topics in Medicinal Chemistry The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Chemical and physical factors influencing the dynamics of differentiation in embryonic stem cells
Current Stem Cell Research & Therapy Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic Acid
Inflammation & Allergy - Drug Targets (Discontinued) Amyloidogenicity and Aggregate Cytotoxicity of Human Glucagon-Like Peptide-1 (hGLP-1)
Protein & Peptide Letters Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease
Current Drug Targets - Inflammation & Allergy Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs
Current Drug Targets - CNS & Neurological Disorders Editorial [ Anti-Angiogenesis Agents Executive Editor: Cezary Marcinkiewicz ]
Current Pharmaceutical Design Towards Prevention of Ovarian Cancer
Current Cancer Drug Targets Antimicrobial Potential of Botanicals and Disease Control
The Natural Products Journal Inflammatory Mediators in Smoke Inhalation Injury
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Site-directed Fragnomics and MD Simulations Approaches to Identify Interleukin-2 Inhibitors
Medicinal Chemistry Sedation and Analgesia in Pediatric Intensive Care
Current Drug Targets Disorders of Respiration and Sleep-Disordered Breathing in Patients with Chronic Renal Failure
Current Respiratory Medicine Reviews